TipRanks
Satellos Bioscience (MSLE)
NASDAQ:MSLE
US Market
MSLE
Satellos Bioscience
RESEARCH TOOLSreports

Satellos Bioscience (MSLE) Stock News & Sentiment

45 Followers
Satellos Secures Long-Term U.S. Patent Protection for Lead Drug Forazapadin
Premium
Company Announcements
Satellos Secures Long-Term U.S. Patent Protection for Lead Drug Forazapadin
1d ago
6K
MSLE
Analyst Reiterates Buy on Satellos Bioscience, Maintains Unchanged $22 Price Target Amid Steady DMD Trial Progress
Premium
Ratings
Analyst Reiterates Buy on Satellos Bioscience, Maintains Unchanged $22 Price Target Amid Steady DMD Trial Progress
6d ago
MSLE
Satellos Completes Enrollment in BASECAMP Phase 2 Trial of Forazapadin for Duchenne Muscular Dystrophy
Premium
Company Announcements
Satellos Completes Enrollment in BASECAMP Phase 2 Trial of Forazapadin for Duchenne Muscular Dystrophy
6d ago
6K
MSLE
Satellos Bioscience: Regulatory Advances and Upcoming DMD Readouts Support Buy Rating, Price Target Maintained at $22
Premium
Ratings
Satellos Bioscience: Regulatory Advances and Upcoming DMD Readouts Support Buy Rating, Price Target Maintained at $22
12d ago
MSLE
Satellos Wins FDA Green Light for FSHD Trial and Secures Up to US$5 Million in Non-Dilutive Funding
Premium
Company Announcements
Satellos Wins FDA Green Light for FSHD Trial and Secures Up to US$5 Million in Non-Dilutive Funding
12d ago
MSLE
Satellos Bioscience to Showcase Forazapadin Program at World Muscle Society Congress
Premium
Company Announcements
Satellos Bioscience to Showcase Forazapadin Program at World Muscle Society Congress
21d ago
6K
MSLE
Satellos Bioscience Secures INN ‘Forazapadin’ for Lead Duchenne Drug as Phase 2 Programs Advance
Premium
Company Announcements
Satellos Bioscience Secures INN ‘Forazapadin’ for Lead Duchenne Drug as Phase 2 Programs Advance
27d ago
6K
MSLE
More MSLE News >

MSLE News on the Web

Analysts Are Bullish on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Kyverna Therapeutics, Inc. (KYTX)
TipRanks News
Bullish
Satellos Bioscience to Showcase DMD Drug Program at September Investor Conferences
TipRanks News
Neutral
LifeSci Capital Sticks to Their Buy Rating for Satellos Bioscience (MSLE)
TipRanks News
Bullish
Satellos Bioscience Sets Up US$50 Million U.S. At-the-Market Share Sales Facility
TipRanks News
Neutral
Top Biotech Gainers: ZCMD Surges 190%, LABT Advances On Nu-3 Progress, ARWR Hits The Targets
rttnews
Bullish
Satellos Bioscience Posts Encouraging Six-Month TRAILHEAD Data in Adult DMD Patients
TipRanks News
Neutral
Guggenheim Keeps Their Buy Rating on Satellos Bioscience (MSLE)
TipRanks News
Bullish
Satellos' SAT-3247 Wins FDA Fast Track Status For Duchenne Muscular Dystrophy, Stock Up
rttnews
Bullish

News Score - Last 7 Days

Very Positive
MSLE
Sector Average
Media Buzz
This Week7 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MSLE’s Media Buzz Sentiment?
7 articles about MSLE were published this week. In an average week, 1.75 articles are published.
    What is MSLE’s weekly average amount of articles?
    In an average week, 1.75 articles about MSLE are published.
      What is MSLE’s News Sentiment?
      100% of articles about MSLE were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XERSXeris Pharmaceuticals
        QTTBQ32 Bio
        ABTAbbott Laboratories
        GMABGenmab
        BAYRYBayer
        Showing the stocks with the most bullish news sentiment over the past week